Nilotinib-d6
Code | Size | Price |
---|
TAR-T12224-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T12224-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Nilotinib D6 is a deuterium labeled Nilotinib which is an orally available inhibitor of Bcr-Abl tyrosine kinase ,and with antineoplastic activity.
CAS:
1268356-17-7
Formula:
C28H22F3N7O
Molecular Weight:
535.55
Purity:
0.98
SMILES:
C(F)(F)(F)C=1C=C(C=C(NC(=O)C2=C(C(NC=3N=C(C=CN3)C=4C=CC=NC4)=C(C([2H])([2H])[2H])C(=C2[2H])[2H])[2H])C1)N5C=NC(C)=C5
References
Weisberg E, et al. Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias. Blood. 2007 Mar 1;109(5):2112-20.